72. Evaluation of Acclerate Pheno™ on Clinical and Antimicrobial Outcomes in Patients with Methicillin Susceptible Staphylococcus aureus Bloodstream Infections

BACKGROUND: Anti-staphylococcal beta-lactams (BL) are treatment of choice for methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSI) as they have superior MSSA bacteremia clearance. Based on the hypothesis that earlier initiation of anti-staphylococcal BL may improve clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Deanna, DePasquale, William P, Staicu, Mary L, Stainton, Sean, Hite, Mindee, Laguio-Vila, Maryrose R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644940/
http://dx.doi.org/10.1093/ofid/ofab466.274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644940/
http://dx.doi.org/10.1093/ofid/ofab466.274

Ejemplares similares